KYMERA THERAPEUTICS INC (KYMR:NASDAQ)
$118.81 0.66 (0.5586%)
Analysed KYMERA THERAPEUTICS INC (KYMR:NASDAQ) News Sources
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates
05-08-2026
yahoo.com
Kymera Therapeutics Q2 Earnings Call Highlights
05-08-2026
marketbeat.com
KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments
06-08-2026
yahoo.com
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
01-09-2026
yahoo.com
Kymera Therapeutics, Inc. Q2 2026 Earnings Call Summary
05-08-2026
moby.co
Kymera's CEO Sold $6 Million in Stock After a 170% Run
12-07-2026
fool.com
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
27-07-2026
yahoo.com
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
28-07-2026
yahoo.com
Accelerated KT-621 Trial and Narrower Loss Might Change The Case For Investing In Kymera Therapeutics (KYMR)
06-08-2026
yahoo.com
Kymera Therapeutics (KYMR) Q2 2026 Earnings Call Transcript
12-08-2026
fool.com
What is the current price of KYMERA THERAPEUTICS INC (KYMR:NASDAQ)?
The current price of KYMERA THERAPEUTICS INC (KYMR:NASDAQ) is $118.81.
KYMERA THERAPEUTICS INC (KYMR:NASDAQ) absolute price change since previous trading day?
The absolute price change of KYMERA THERAPEUTICS INC (KYMR:NASDAQ) since the previous trading day is $0.66.
KYMERA THERAPEUTICS INC (KYMR:NASDAQ) percentage price change since previous trading day?
The percentage price change of KYMERA THERAPEUTICS INC (KYMR:NASDAQ) since the previous trading day is 0.5586%.
What is the most recent average sentiment score for KYMERA THERAPEUTICS INC (KYMR:NASDAQ)?
The most recent average sentiment score for KYMERA THERAPEUTICS INC (KYMR:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for KYMERA THERAPEUTICS INC (KYMR:NASDAQ)?
The most recent sentiment for KYMERA THERAPEUTICS INC (KYMR:NASDAQ) is .
SEC-8K** Filing Available For KYMERA THERAPEUTICS INC (KYMR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.